<DOC>
	<DOCNO>NCT02902393</DOCNO>
	<brief_summary>Revascularisation use recombinant tPA reference treatment stroke . However , efficacy fibrinolysis 50 % . Several factor , include size thrombus , associate revascularisation efficacy . The aim prospective study evaluate ex vivo effect tPA patient stroke thromboelastography correlate result clinical outcome patient . Results may predict revascularisation patient stroke .</brief_summary>
	<brief_title>Interest Thromboelastography ( ROTEM ) Biomarker Revascularisation Stroke</brief_title>
	<detailed_description />
	<mesh_term>Stroke</mesh_term>
	<criteria>Patient ( &gt; 18 year ) neurological deficit compatible neurovascular pathology eligible fibrinolysis rtPA proximal occlusion middle cerebral artery ( segment M1 / M2 ) basilar trunk objectify brain imaging ( MRI angiography angio CT ) . Any patient major comorbidity , pathology hemostasis anticoagulant treatment ( vitamin K antagonist ( VKA ) , direct oral anticoagulant ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Fibrinolysis</keyword>
	<keyword>tPA</keyword>
</DOC>